Page last updated: 2024-08-25

oxazolidin-2-one and Cerebral Ventriculitis

oxazolidin-2-one has been researched along with Cerebral Ventriculitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anderson, TA; Kiser, TH; Mueller, SW; Neumann, RT	1

Other Studies

1 other study(ies) available for oxazolidin-2-one and Cerebral Ventriculitis

Article	Year
Intraventricular daptomycin and intravenous linezolid for the treatment of external ventricular-drain-associated ventriculitis due to vancomycin-resistant Enterococcus faecium. The Annals of pharmacotherapy, 2012, Volume: 46, Issue:12 Topics: Acetamides; Administration, Intravenous; Anti-Bacterial Agents; Cerebral Ventriculitis; Daptomycin; Dose-Response Relationship, Drug; Drainage; Drug Therapy, Combination; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Injections, Intraventricular; Linezolid; Male; Middle Aged; Oxazolidinones; Treatment Outcome; Vancomycin Resistance	2012

Article

Year

Intraventricular daptomycin and intravenous linezolid for the treatment of external ventricular-drain-associated ventriculitis due to vancomycin-resistant Enterococcus faecium.

The Annals of pharmacotherapy, 2012, Volume: 46, Issue:12

Topics: Acetamides; Administration, Intravenous; Anti-Bacterial Agents; Cerebral Ventriculitis; Daptomycin; Dose-Response Relationship, Drug; Drainage; Drug Therapy, Combination; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Injections, Intraventricular; Linezolid; Male; Middle Aged; Oxazolidinones; Treatment Outcome; Vancomycin Resistance

2012